Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1040b added to anticoagulation for acute submassive pulmonary embolism
NL-OMON47535Phase 1Completed
- Sponsor
- Daiichi Sankyo, Inc
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pulmonary embolism (PE) comparing DS-1040b + standard anticoagulation with Placebo + standard anticoagulation (2 arms). Primary endpoint: Adjudicated clinically relevant bleeding. Started Jul 2017; status: completed.
02
Drugs
DS1040b
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NL-OMON47535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47535.